补充描述:
Binimetinib film-coated tablets are supplied in 15 mg and 45 mg strengths for use with encorafenib in treating melanoma. Coripharma is developing a generic version at its Iceland R&D facility, which runs entirely on sustainable energy, with pivotal bioequivalence studies planned for Q4 2025, dossier availability targeted for Q2 2026, and a DCP slot requested for September 2026.
留下您的评分和评论